Envisioned by Kofi Annan, former UN Secretary General, as a public-private partnership, the Global Fund to Fight AIDS, TB and Malaria is now the leading funding agency for global health, and a vital partner in the business fight against these pandemics.

GBCHealth serves as an entry-point for private sector collaboration with the Global Fund, supporting good governance, orchestrating the private sector delegation on the Global Fund Board of Directors, enabling partnerships and facilitating engagement with the Fund's recipients worldwide.

The Global Fund's scale and reach make it an ideal partner for the private sector, bringing to the table a strategic mix of donor and recipient governments, civil society organizations, private foundations and corporations.            

A performance-driven funding instrument, with solid performance milestones and oversight mechanisms, the Global Fund also represents one of the most efficient avenues for business investment in these pandemics, while also providing strategic opportunities for co-financing and collaboration on the ground. To date, the Global Fund has committed $21.7 billion in funding to more than 572 programs in 150 countries – an unprecedented investment.

>> Read more about The Global Fund and the Private Sector

>> Read the Global Fund Private Sector Delegation 2011 Annual Report

GBCHealth and the Global Fund

Working with Business to Ensure Effective Global Fund Governance and Performance

As the Focal Point for the Private Sector Delegation (PSD) on the Board of the Fund, GBCHealth works with dozens of committed businesses willing to contribute to the Global Fund's agenda, advise the board's deliberations, ensure that the body remains performance-driven and advocate for the business role in global health.

The PSD Focal Point, Anna Thompson-Quaye, works hand in hand with private sector Board  member and Alternate Board member – at present, Dr. Brian Brink of Anglo American plc and
Ms. Renuka Gadde of BD (Becton, Dickinson and Company) - on their work with the Global Fund Board of Directors. Along with PSD members, this team of private sector representatives helps steer the Fund’s priorities and policies, while also ensuring Global Fund initiatives actively engage the business sector.

Orchestrating PSD Membership

A group of companies and private sector organizations participate in Global Fund matters through the Private Sector Constituency. These companies and organizations are interested in the Global Fund’s mission and opportunities to become engaged with the Fund. Constituency members are kept abreast of key Global Fund news and have the opportunity to provide feedback on select decisions. Constituency members are also invited to participate in Bi-Annual pre-Global Fund Board meetings.

The Constituency is represented at the Global Fund Board level by the Board member, Alternate and Focal Point with guidance of an Advisory Group formed from Constituency members.

The Private Sector Advisory Group was established to help orchestrate enhanced support and engagement with the Global Fund. The group is composed of like-minded companies eager to advance the Fund's agenda and ensure the presence of private sector delegation members at each Board meeting. The Advisory Group elects the Board member, Alternate Board member and Focal Point, and provides input on key funding decisions, policies, and programs most relevant to the private sector. The group engages in high-level meetings and networking events with government and civil society representatives, and also receives individual advisory services on their engagement with the Global Fund. Each Advisory Group member is required to sign a Conflict of Interest (COI) form to ensure the group is acting in the interest of the Global Fund and private sector constituency.

>> View the PSD Overview in PDF

>> View the list of Advisory Group and Constituency Members

Supporting Private Sector Constituency Members’ Global Fund Contributions

• CORPORATE CHAMPION – Chevron became the first Global Fund Corporate Champion in January 2008 when they announced a US$ 30 million commitment to the Global Fund at the World Economic Forum. Since then, they have increased their 6-year investment (2008-2013) to a total of $US 55 million. This is now the largest contribution from a single corporation to the Global Fund.

For more information on Chevron’s role as Corporate Champion, please click here.

• CO-INVESTMENT – SABMiller, SABCOHA and the South African government are partnering with the Global Fund on five HIV/AIDS Initiatives. The Fund’s contribution of R36million is being further strengthened through SABMiller’s additional resources.

For more information on SABMiller’s partnership with the Global Fund, please click here.

• CO-INVESTMENT – Marathon Oil is helping to lead the “Bioko Island Malaria Project” with the Government of Equatorial Guinea, Noble Energy, GEPetrol and SONAGAS. In 2008, these partners announced a 5-year $28million extension of the project with a $26million contribution from the Global Fund.

For more information on the extension of the Bioko Island Malaria Project, please click here.

• ‘GIFT FROM AFRICA’ – Access Bank is leading a collective funding initiative with other African based companies to benefit The Global Fund. The ‘Gift From Africa’ campaign “demonstrate[s] to the world that Africans are prepared to share the responsibility for solving Africa’s challenges” (Aigboje Aig-Imoukhuede, Group Managing Director, Access Bank and Chairman of Friends of the Global Fund Africa)

For more information on Access Bank and ‘Gift from Africa’, please click here.

• CORPORATE PLEDGE at G20 BUSINESS SUMMIT – Anglo American plc with Takeda Pharmaceuticals led a Call for Joint Action on Global Health at the G20 Business Summit in Seoul, South Korea. At the Summit, Anglo American pledged a contribution of $US 3 million to the Global Fund over 3 years.

For more information on Anglo American’s Global Fund contribution, please click here.

• IN-KIND CONTRIBTUTIONS – Novartis and Sanofi, leading manufacturers of artemisinin-based combination therapies (ACTs), the most effective malaria treatment, are providing their medicines at not-for-profit prices to increase access to those in most need. Their contributions are being channeled through the Affordable Medicines Facility – malaria (AMFm) initiative, which is managed by the Global Fund.

For more information on AMFm, please click here.

• PRO-BONO SERVICES – Standard Bank and the Global Fund entered into a pro-bono partnership in December 2008 in which the Bank provides financial and management training to grant recipients in select countries.  It is entirely demand-driven and free of any conditionality. The partnership is currently active in Uganda, Nigeria, Swaziland, Lesotho, Mozambique and Zimbabwe.

For more information on the Standard Bank partnership, please click here.

• INNOVATIVE FINANCING – Product (RED) was created by Bono to generate sustainable funds for life-saving HIV/AIDS treatment in Africa. The campaign has attracted a range of companies from Starbucks to Dell to create (RED) products with proceeds benefiting the Global Fund. To date, (RED) products have raised more than $160 million for Global Fund programs.

For more information on Product (RED), please click here.

• ​SUPPLY CHAIN MANAGEMENT – Coca-Cola is working with the Tanzanian Ministry of Health’s Medical Stores Department (MSD) to assist with their supply chain management and ensure essential medicines are made available in a time/cost-effective manner. Tanzania has the second largest Global Fund grant in Sub-Saharan Africa. Early outcomes from the pilot project have shown a 25% cost savings on the distribution network.

For more information on the Coca-Cola’s sustainability programs, please click here.

• PRIMARY RECIPIENT OF GLOBAL FUND GRANT – AngloGold Ashanti became the first private sector Principal Recipient in Africa with a Global Fund grant of up to US $130 million. Through this additional funding they will expand their successful integrated malaria control program into 40 districts in Ghana, through a public-private partnership model.

For more information on AngloGold Ashanti's malaria control program, please click here.

Facilitating In-country Engagement

Many GBCHealth members are actively involved with the Global Fund's Country Coordinating Mechanisms (CCMs), the local multi-sector bodies overseeing the Global Fund grant application and stewardship process in country. Initiatives that are approved by the CCMs and implemented on the ground are frequently in need of co-financing or management support from the private sector.

GBCHealth Members on CCMs:

    *List current as of March 2012

GBCHealth identifies opportunities to connect member companies to such strategic opportunities on the ground, identifying gaps where business competencies or resources can make real impact. The PSD Focal Point also works with National Business Coalitions (NBCs) to ensure their in-country knowledge and expertise is reflected at the Board level.

The Global Fund in Action: Key Statistics and Impact

Global Fund-supported Programs Contribute to International Targets

Global Fund Top 3 Indicators in 2011

Disbursements by the Global Fund in 2010

Additional Resources and External Links

>>Read GBCHealth’s Private Sector Guide to the Global Fund

>>Review the Global Fund 2011 Results Report

>>Sign up for the Global Fund Observer free e-newsletter about the Global Fund

>>Listen to African Health Ministers talk about the Global Fund in Rwanda, Botswana and Lesotho

>>Read "Global Fund and Big Business Partner against AIDS" from Voice of America

>>Learn more about The Global Fund

For more information about the Global Fund Private Sector Delegation or to receive upcoming PSD Newsletters, please contact Anna Thompson-Quaye, Focal Point, at psd@gbchealth.org.